Prognosis
Illumina Aims to Push Genetics Beyond the Lab With $200 Genome
- New machine pushes company toward goal of $100 genome sequence
- Could be boon for gene-targeting drugs, Regeneron exec says
This article is for subscribers only.
Illumina Inc. says it can read a person’s entire genetic code for as little as $200 with its new sequencing machine, bringing the company within reach of its long-promised goal of the $100 genome.
Illumina on Thursday unveiled a new line of DNA sequencing machines it says are twice as fast and accurate as its earlier models. Together, those upgrades will bring the cost per genome down two-thirds from its current technology, Chief Executive Officer Francis deSouza said.